Healthcare provider profile · identity verified

Deborah J Hower, MD

Internal Medicine · EAU CLAIRE, WI · NPI 1073593257

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	438	118
Levothyroxine Sodium	Levothyroxine Sodium	425	124
Losartan Potassium	Losartan Potassium	356	105
Rosuvastatin Calcium	Rosuvastatin Calcium	337	100
Amlodipine Besylate	Amlodipine Besylate	320	97
Lisinopril	Lisinopril	290	74
Omeprazole	Omeprazole	257	83
Sertraline Hcl	Sertraline Hcl	203	53
Pantoprazole Sodium	Pantoprazole Sodium	199	55
Metoprolol Succinate	Metoprolol Succinate	196	57
Gabapentin	Gabapentin	188	51
Eliquis	Apixaban	162	33
Metformin Hcl Er	Metformin Hcl	155	54
Trazodone Hcl	Trazodone Hcl	132	38
Duloxetine Hcl	Duloxetine Hcl	130	36
Potassium Chloride	Potassium Chloride	128	32
Metoprolol Tartrate	Metoprolol Tartrate	123	43
Furosemide	Furosemide	121	29
Simvastatin	Simvastatin	120	30
Ozempic	Semaglutide	114	27
Spironolactone	Spironolactone	112	25
Alendronate Sodium	Alendronate Sodium	104	32
Hydrochlorothiazide	Hydrochlorothiazide	103	33
Tramadol Hcl	Tramadol Hcl	103	25
Allopurinol	Allopurinol	79	18
Metformin Hcl	Metformin Hcl	79	24
Alprazolam	Alprazolam	75	26
Carvedilol	Carvedilol	73	20
Pravastatin Sodium	Pravastatin Sodium	73	21
Tamsulosin Hcl	Tamsulosin Hcl	73	25
Atenolol	Atenolol	72	27
Venlafaxine Hcl Er	Venlafaxine Hcl	68	14
Bupropion Xl	Bupropion Hcl	62	16
Fluticasone Propionate	Fluticasone Propionate	60	36
Famotidine	Famotidine	59	17
Montelukast Sodium	Montelukast Sodium	59	13
Fluoxetine Hcl	Fluoxetine Hcl	56	19
Mounjaro	Tirzepatide	56	16
Ezetimibe	Ezetimibe	55	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	12
Albuterol Sulfate Hfa	Albuterol Sulfate	53	24
Jardiance	Empagliflozin	51	17
Mirtazapine	Mirtazapine	47	13
Escitalopram Oxalate	Escitalopram Oxalate	46	11
Clonazepam	Clonazepam	45	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	11
Zolpidem Tartrate	Zolpidem Tartrate	41	13
Lorazepam	Lorazepam	39	15
Incruse Ellipta	Umeclidinium Bromide	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Bupropion Hcl	Bupropion Hcl	36	suppressed
Pregabalin	Pregabalin	36	13
Synthroid	Levothyroxine Sodium	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	14
Prednisone	Prednisone	34	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Lovastatin	Lovastatin	32	11
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	31	suppressed
Glimepiride	Glimepiride	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	17
Finasteride	Finasteride	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	14
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Meloxicam	Meloxicam	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	17
Trulicity	Dulaglutide	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Estradiol	Estradiol	20	11
Lansoprazole	Lansoprazole	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Amoxicillin	Amoxicillin	17	12
Clindamycin Phosphate	Clindamycin Phosphate	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Serevent Diskus	Salmeterol Xinafoate	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Estradiol (Once Weekly)	Estradiol	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	13
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Dofetilide	Dofetilide	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Valsartan	Valsartan	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Baclofen	Baclofen	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Glipizide	Glipizide	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Diazepam	Diazepam	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error